RLX · NYSE · Tobacco

RELX Technology (ADR) (RLX)

Sells compliant RELX vaping products in China and selected international markets.

$1.73
vs last close−0.02 (−1.15%)

In millions of USD, except per-share figures · converted from CNY at the latest rate

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue49787083101110106119154159218136
Cost of revenue335749607177718210210614583
Gross profit162121243133343653537353
224129293235233039353734
Research & development535045446554
173824292930192633303229
Selling & marketing668910791320000
General & administrative113116191823101313000
Operating income−6−20−8−5−2−212614183619
325530283125263124271417
Interest income24242423232220213221817
Other non-operating income0−55−30−28−31−25−26−31−24−27−140
Income before tax263522233023373738455037
Income tax expense022354447274
Net income from continuing operations263320202519333331424433
Net income263220202518333230414232
EPS, basic$0.02$0.02$0.02$0.02$0.02$0.01$0.03$0.03$0.03$0.03$0.03$0.03
EPS, diluted$0.02$0.02$0.01$0.01$0.02$0.01$0.03$0.03$0.02$0.03$0.03$0.03
Weighted average shares, basic1,3161,3241,2491,2291,2251,2921,2261,2221,2941,2311,2321,226
Weighted average shares, diluted1,3441,3241,3011,2841,2881,2921,3091,3091,2951,2321,3131,307
EBITDA−33722233024373739585219
Depreciation & amortization3200020021420
EBIT−63522233023373738455019